{"id":1656,"date":"2024-03-03T14:34:46","date_gmt":"2024-03-03T17:34:46","guid":{"rendered":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/?page_id=1656"},"modified":"2024-11-11T21:03:50","modified_gmt":"2024-11-12T00:03:50","slug":"pagina-22-gestante-em-reinicio-de-tarv-apos-abandono","status":"publish","type":"page","link":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/pagina-22-gestante-em-reinicio-de-tarv-apos-abandono","title":{"rendered":"P\u00e1gina 22 – GESTANTE EM REIN\u00cdCIO DE TARV AP\u00d3S ABANDONO"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

GESTANTE EM REIN\u00cdCIO DE TARV AP\u00d3S ABANDONO<\/h1>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

A mulher vivendo com HIV (MVHIV) em situa\u00e7\u00e3o de abandono de TARV e que engravida deve, assim que for readmitida no servi\u00e7o, passar por avalia\u00e7\u00e3o de sintomas e exame f\u00edsico, investiga\u00e7\u00e3o de poss\u00edveis infec\u00e7\u00f5es oportunistas, coleta de CV-HIV contagem de LT-CD4+ e iniciar um esquema de TARV de resgate conforme as orienta\u00e7\u00f5es a seguir.\u00a0<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
  1. Hist\u00f3rico de esquemas de TARV;<\/span><\/li>
  2. Falhas virol\u00f3gicas e testes de genotipagem pr\u00e9vios;<\/span><\/li>
  3. Contagem de LT-CD4 e exame de CV-HIV;<\/span><\/li>
  4. Motivo da interrup\u00e7\u00e3o da TARV, com o objetivo de avaliar dificuldades na adapta\u00e7\u00e3o ou intoler\u00e2ncia medicamentosa;<\/span><\/li>
  5. Idade gestacional \u2013 especial aten\u00e7\u00e3o \u00e0s gestantes admitidas no terceiro trimestre em situa\u00e7\u00e3o de abandono.<\/span><\/li><\/ol>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\"Ilustra\u00e7\u00e3o\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
      \n
    1. Recomenda-se iniciar empiricamente a TARV com dois ITRN associados a um IP\/r (preferencialmente Darunavir (DRV\/R), na posologia de 600mg\/100mg de 12\/12h);<\/span><\/li>\n
    2. Ap\u00f3s quatro a seis semanas de uso efetivo de TARV, deve-se coletar nova CV-HIV e, se detect\u00e1vel,realizar genotipagem para avalia\u00e7\u00e3o do tratamento e readequa\u00e7\u00e3o do esquema de TARV;<\/span><\/li>\n
    3. Nos casos de gestante em abandono de TARV, com readmiss\u00e3o tardia no pr\u00e9-natal (3\u00ba trimestre), considerar esquema contendo inibidores de integrase, preferencialmente o Dolutegravir (DTG), em fun\u00e7\u00e3o da capacidade de atingir a supress\u00e3o viral mais rapidamente.<\/span><\/li>\n<\/ol>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t
      \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tP\u00e1gina Inicial<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t
      \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tDiagn\u00f3stico<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t
      \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tTratamento<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t
      \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tSeguimento<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t
      \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tTabela de Siglas e Abreviaturas<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

      GESTANTE EM REIN\u00cdCIO DE TARV AP\u00d3S ABANDONO A mulher vivendo com HIV (MVHIV) em situa\u00e7\u00e3o de abandono de TARV e que engravida deve, assim que for readmitida no servi\u00e7o, passar por avalia\u00e7\u00e3o de sintomas e exame f\u00edsico, investiga\u00e7\u00e3o de poss\u00edveis infec\u00e7\u00f5es oportunistas, coleta de CV-HIV contagem de LT-CD4+ e iniciar um esquema de TARV de […]<\/p>\n","protected":false},"author":7780,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[92],"tags":[],"class_list":["post-1656","page","type-page","status-publish","hentry","category-hiv-novo"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/wp-json\/wp\/v2\/pages\/1656","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/wp-json\/wp\/v2\/users\/7780"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/wp-json\/wp\/v2\/comments?post=1656"}],"version-history":[{"count":0,"href":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/wp-json\/wp\/v2\/pages\/1656\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/wp-json\/wp\/v2\/media?parent=1656"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/wp-json\/wp\/v2\/categories?post=1656"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ufsm.br\/pet\/ciencia-da-computacao\/wp-json\/wp\/v2\/tags?post=1656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}